Related Experiment Video
Updated: Jul 26, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
The role of monocytes in thrombotic diseases: a review
Zhongyu Han1, Qiong Liu1, Hongpeng Li1
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Insights
Monocytes, key immune cells, significantly contribute to cardiovascular thrombotic events. Understanding monocyte subsets and their role in thrombosis offers potential new therapeutic strategies for cardiovascular diseases.
Area of Science:
- Cardiovascular and cerebrovascular diseases research
- Immunology and thrombosis
- Innate immunity and cardiovascular health
Background:
- Cardiovascular and cerebrovascular diseases are leading causes of mortality, with thrombotic events being the most frequent.
- Thrombosis can precipitate life-threatening conditions like acute coronary syndrome and cerebral infarction.
- Circulating monocytes, crucial for innate immunity, also play a role in coagulation and anticoagulation processes.
Purpose of the Study:
- To review the intricate relationship between distinct monocyte subsets and cardiovascular thrombotic events.
- To elucidate the specific roles of monocytes in arterial thrombosis and their involvement in intravenous thrombolysis.
- To summarize current understanding of monocyte-thrombosis mechanisms and therapeutic approaches in various cardiovascular conditions.
Main Methods:
- Literature review focusing on monocyte subsets and thrombotic events.
- Analysis of monocyte functions in arterial thrombosis and thrombolysis.
- Synthesis of data on monocyte-thrombosis interplay in specific diseases.
Main Results:
- Monocytes are increasingly recognized for their significant involvement in thrombosis and immune-related thrombotic diseases.
- Specific monocyte subsets demonstrate distinct roles in the pathogenesis of cardiovascular thrombotic events.
- Mechanisms linking monocytes to thrombosis in conditions like hypertension and atherosclerosis are being uncovered.
Conclusions:
- Monocyte subsets are critical players in the development and progression of cardiovascular thrombotic events.
- Targeting monocyte pathways presents a promising avenue for novel therapeutic interventions against thrombosis.
- Further research into monocyte-thrombosis mechanisms is essential for developing effective treatment regimens.
Abstract:
Cardiovascular and cerebrovascular diseases are the number one killer threatening people's life and health, among which cardiovascular thrombotic events are the most common. As the cause of particularly serious cardiovascular events, thrombosis can trigger fatal crises such as acute coronary syndrome (myocardial infarction and unstable angina), cerebral infarction and so on. Circulating monocytes are an important part of innate immunity. Their main physiological functions are phagocytosis, removal of injured and senescent cells and their debris, and development into macrophages and dendritic cells. At the same time, they also participate in the pathophysiological processes of pro-coagulation and anticoagulation. According to recent studies, monocytes have been found to play a significant role in thrombosis and thrombotic diseases of the immune system. In this manuscript, we review the relationship between monocyte subsets and cardiovascular thrombotic events and analyze the role of monocytes in arterial thrombosis and their involvement in intravenous thrombolysis. Finally, we summarize the mechanism and therapeutic regimen of monocyte and thrombosis in hypertension, antiphospholipid syndrome, atherosclerosis, rheumatic heart disease, lower extremity deep venous thrombosis, and diabetic nephropathy.
Related Concept Videos
Inflammation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease II: Pathophysiology
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis I: Introduction

